Archives
- 2026-05
- 2026-04
- 2026-03
- 2026-02
- 2026-01
- 2025-12
- 2025-11
- 2025-10
- 2025-09
- 2025-03
- 2025-02
- 2025-01
- 2024-12
- 2024-11
- 2024-10
- 2024-09
- 2024-08
- 2024-07
- 2024-06
- 2024-05
- 2024-04
- 2024-03
- 2024-02
- 2024-01
- 2023-12
- 2023-11
- 2023-10
- 2023-09
- 2023-08
- 2023-07
- 2023-06
- 2023-05
- 2023-04
- 2023-03
- 2023-02
- 2023-01
- 2022-12
- 2022-11
- 2022-10
- 2022-09
- 2022-08
- 2022-07
- 2022-06
- 2022-05
- 2022-04
- 2022-03
- 2022-02
- 2022-01
- 2021-12
- 2021-11
- 2021-10
- 2021-09
- 2021-08
- 2021-07
- 2021-06
- 2021-05
- 2021-04
- 2021-03
- 2021-02
- 2021-01
- 2020-12
- 2020-11
- 2020-10
- 2020-09
- 2020-08
- 2020-07
- 2020-06
- 2020-05
- 2020-04
- 2020-03
- 2020-02
- 2020-01
- 2019-12
- 2019-11
- 2019-10
- 2019-09
- 2019-08
- 2019-07
- 2018-07
-
Sunitinib in Cancer Research: Overcoming Resistance via Ferr
2026-05-11
Explore how Sunitinib, a multi-targeted receptor tyrosine kinase inhibitor, is revolutionizing cancer research by leveraging ferroptosis to overcome resistance in renal cell carcinoma. Discover novel assay design strategies and actionable insights distinct from prior content.
-
PFOS Induces Ferroptosis and ER Stress in HK-2 Renal Cells
2026-05-11
This study elucidates how perfluorooctane sulfonate (PFOS) causes cytotoxicity in human kidney HK-2 cells via ferroptosis and endoplasmic reticulum (ER) stress pathways. By identifying distinct molecular markers and mechanisms, the work advances understanding of PFOS nephrotoxicity and provides a foundation for future research on ER stress alleviation and chemical chaperones.
-
CUDC-907: Practical Guidance for Dual PI3K and HDAC Inhibiti
2026-05-10
CUDC-907 is a dual PI3K and HDAC inhibitor intended for cell-based in vitro research on cancer signaling, cell cycle, and apoptosis pathways. It should be used only in controlled laboratory settings, with careful adherence to recommended protocols. CUDC-907 is not suitable for diagnostic or therapeutic applications.
-
METTL16-SENP3-LTF Axis Drives Ferroptosis Resistance in HCC
2026-05-09
Wang et al. (2024) identify the METTL16-SENP3-LTF axis as a key regulator of ferroptosis resistance and tumorigenesis in hepatocellular carcinoma (HCC). Their mechanistic study highlights m6A-dependent regulation of iron metabolism as a promising therapeutic target for sensitizing HCC to ferroptosis.
-
Berberrubine Inhibits Thrombosis via Vitamin K Cycle Modulat
2026-05-08
This study demonstrates that berberrubine, a principal berberine metabolite, inhibits thrombosis in mice by targeting enzymes of the vitamin K catalytic cycle. Using integrated metabolomics and molecular docking, researchers elucidated a distinct antithrombotic mechanism with reduced bleeding risk, offering a foundation for safer anticoagulant development.
-
α2-AR Agonist Hydrogel Modulates Immune Rejection in Osteosa
2026-05-08
This study explores the use of α2-adrenergic receptor agonists, delivered via a thermo-sensitive hydrogel, to reduce immune rejection and recurrence in post-surgical osteosarcoma models. Findings indicate that immune modulation—particularly T cell activation—rather than direct cytotoxicity, underpins the observed anti-tumor effects, providing a mechanistic basis for novel immunotherapeutic approaches.
-
Verapamil HCl: Applied Workflows in Calcium Channel Blockade
2026-05-07
Verapamil HCl stands out as a versatile L-type calcium channel blocker for advanced research on apoptosis, inflammation, and osteoporosis models. This guide translates recent breakthroughs and best-practice protocols into actionable steps for reproducible cell and animal studies.
-
Cy5 TSA Fluorescence System Kit: Amplified Sensitivity in IH
2026-05-07
The Cy5 TSA Fluorescence System Kit transforms detection of low-abundance biomolecules in immunohistochemistry, immunocytochemistry, and in situ hybridization through 100-fold signal amplification and rapid, covalent Cy5 labeling. This article details optimized workflows, troubleshooting strategies, and key innovations inspired by recent astrocyte transcriptomic breakthroughs.
-
Kanamycin Sulfate: Mechanism, Strategy, and Translational Vi
2026-05-06
This thought-leadership article explores Kanamycin Sulfate’s mechanistic action as a water-soluble aminoglycoside antibiotic, its pivotal application in modern microbiology and antibiotic resistance research, and strategic guidance for translational scientists. Integrating mechanistic detail, competitive context, and the latest advances in RNA bioprocessing, the article goes beyond protocol guides to map the future of robust, reproducible research.
-
VER 155008: HSP 70 Inhibitor Advances Apoptosis Assays in Ca
2026-05-06
VER 155008, a potent adenosine-derived HSP 70 inhibitor, empowers researchers to dissect chaperone-mediated pathways and apoptosis in cancer and neurodegeneration models. This guide translates recent mechanistic discoveries into actionable workflows, troubleshooting strategies, and optimized experimental parameters for superior assay performance.
-
Freeze-Induced Betaine Loading Boosts LNP mRNA Delivery Effi
2026-05-05
This study demonstrates that freezing lipid nanoparticles (LNPs) with the cryoprotectant betaine leads to its incorporation into LNPs through freeze concentration, significantly enhancing mRNA delivery efficacy. The work redefines the role of cryoprotectants, showing they can actively modulate LNP structure and function, opening new avenues for robust mRNA therapeutic development.
-
Dual-Action Kinase Inhibitors Modulate p38α Dephosphorylatio
2026-05-05
The referenced study reveals that certain kinase inhibitors can promote dephosphorylation of p38α MAP kinase by stabilizing its activation loop in a conformation accessible to phosphatases. This dual-action effect suggests new strategies to enhance the potency and specificity of kinase-targeted therapeutics by leveraging conformational control.
-
GANT61: Advanced GLI Inhibitor Workflows for Cancer Research
2026-05-04
GANT61 empowers precise inhibition of GLI1/GLI2, enabling researchers to dissect Hedgehog signaling and overcome tumor immune evasion. This guide details experimental workflows, protocol optimizations, and troubleshooting strategies to maximize the impact of GANT61 in translational cancer research.
-
Tamsulosin in Applied Urological Research: Protocols & Solut
2026-05-04
Leverage Tamsulosin's highly selective α₁A-adrenergic antagonism for advanced urological and smooth muscle research. This guide delivers stepwise protocols, assay-specific troubleshooting, and actionable insights—bridging clinical evidence with bench workflows and highlighting the practical impact of recent biomarker-driven findings.
-
Jasplakinolide: Actin Polymerization Inducer for Advanced Ce
2026-05-03
Jasplakinolide stands out as a benchmark actin polymerization inducer, enabling precise manipulation of cytoskeletal dynamics in live-cell studies. This guide delivers actionable workflows, troubleshooting insights, and a direct bridge from recent literature to optimized experimental design.